| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y111-01015 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44 |
| filingDate |
2002-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3cb14d951252160b3fb4a06aade036b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50faf571e0a59353e8fad5a4e21ed5e4 |
| publicationDate |
2002-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002168353-A1 |
| titleOfInvention |
Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof |
| abstract |
The invention includes compositions comprising substantially purified peroxiredoxin that are useful in methods for the treatment and prevention of HIV-1 infection. The invention also includes methods for the treatment and prevention of HIV-1 infection comprising contacting a composition of the invention with a human patient. Additionally, the invention includes antibodies and kits useful in the treatment and prevention of HIV-1 infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8003345-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007292406-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010226905-A9
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7794708-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006147440-A1 |
| priorityDate |
2001-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |